1. IndiaInfoline
  2. Search
Displaying Results for "biocon"
Showing Results 1 - 19 of 843

Biocon fixes record date for declaration of Interim Dividend

India Infoline News Service  | Mumbai March 27, 2015 09:39 IST

The company has approved the payment of Interim Dividend at a rate of 100% i.e(Rs.5/-per share) for the Financial Year 2014-15.

Biocon fixes record date for interim dividend

capital market  | Mumbai March 27, 2015 09:36 IST

Record date is 10 April 2015

Biocon plans to invest 10% of Biopharma revenues on R&D

India Infoline News Service  | Mumbai February 02, 2015 09:05 IST

Report said that the company had spent around Rs 131 crore on R&D in the previous fiscal year.

Biocon (Q3 FY15)

India Infoline News Service  | Mumbai January 28, 2015 11:28 IST

Biocon owns a promising portfolio but given the higher risks in biosimilars compared to small molecules and lack of near term triggers has led to stock derating over the past several months.

Biocon edges higher on govt's plans to support biotech industry

capital market  | Mumbai January 28, 2015 10:22 IST

Biocon rose 0.58% to Rs 410.50 at 10:35 IST on BSE after Minister of State Dr. Jitendra Singh yesterday, 27 January 2015, said the government is keen to promote all kinds of upward activities in the biotech sector.

Biocon consolidated net profit declines 13.39% in the December 2014 quarter

capital market  | Mumbai January 23, 2015 10:46 IST

Sales rise 8.55% to Rs 761.09 crore

Biocon standalone net profit declines 4.47% in the December 2014 quarter

capital market  | Mumbai January 23, 2015 10:37 IST

Sales rise 0.89% to Rs 507.94 crore

Biocon stock down 3%

India Infoline News Service  | Mumbai January 23, 2015 09:57 IST

The stock has hit a high of Rs. 422 and a low of Rs.411.

Biocon drops after poor Q3 earnings

capital market  | Mumbai January 23, 2015 09:56 IST

Biocon lost 3.26% to Rs 412.25 at 09:49 IST on BSE after the company's consolidated net profit fell 13.39% to Rs 90.93 crore on 8.25% rise in total income to Rs 778.99 crore in Q3 December 2014 over Q3 December 2013.

Board of Biocon approves appointment of directors

capital market  | Mumbai January 23, 2015 09:14 IST

At meeting held on 22 January 2015

Board of Biocon approves listing of subsidiary

capital market  | Mumbai January 23, 2015 09:12 IST

At meeting held on 22 January 2015

Biocon appoints Jeremy Levin and Vijay Kumar Kuchroo as Additional Independent Directors

India Infoline News Service  | Mumbai January 23, 2015 08:29 IST

Biocon Ltd has announced that the Board of Directors of the Company at its meeting held on January 22, 2015, inter alia, has appointed Jeremy Levin and Dr. Vijay Kumar Kuchroo as Additional Independent Directors of the Company.

Biocon Q3 net profit at Rs909.30 mn

India Infoline News Service  | Mumbai January 23, 2015 08:25 IST

Total Income has increased from Rs. 7195.70 mn for the quarter ended December 31, 2013 to Rs. 7789.90 mn for the quarter ended December 31, 2014.

Biocon Limited - Press Release

capital market  | Mumbai January 23, 2015 00:00 IST

Biocon Limited has informed the Exchange regarding a press release dated January 22, 2015, titled Biocon Q3FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore; Research Services delivers 20% growth; Board approves listing Syngene via offer for sale along with Fact Sheet.

Board of Biocon approves listing of subsidiary

capital market  | Mumbai January 23, 2015 00:00 IST

Biocon announced that the Board of Directors of the Company at its meeting held on 22 January 2015, inter alia, has approved to initiate the process to list its subsidiary, Syngene International. The company would offload 10%-15% of its stake through an offer for sale.

Biocon Q3 FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore

Business Wire  | January 22, 2015 10:53 IST

Biocon Q3 FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore

Cairn India, Biocon results in focus

India Infoline News Service  | Mumbai January 22, 2015 08:34 IST

The results which are expected today are Alembic Ltd, Biocon Ltd, Cairn India, Zee Media Corporation, State Bank of Mysore,

Biocon gains after concluding stake sale in Syngene

capital market  | Mumbai January 13, 2015 11:45 IST

Biocon rose 2.05% to Rs 428.50 at 11:37 IST on BSE after the company concluded sale of 10% stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company.

Biocon completes 10% stake sale in Syngene

India Infoline News Service  | Mumbai January 13, 2015 11:44 IST

Biocon Research Limited, a wholly owned subsidiary of the Company has concluded such sale to IVF.

Back to Top

Reports
News